Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative

American Journal of Clinical Nutrition

Volumn 101, Issue 4, 2015, Pages 824-834

  Brasky, Theodore M ^a   Rodabough, Rebecca J ^c   Liu, Jingmin ^c   Kurta, Michelle L ^d   Wise, Lauren A ^e   Orchard, Tonya S ^b   Cohn, David E ^a   Belury, Martha A ^b   White, Emily ^c   Manson, Joann E ^f   Neuhouser, Marian L ^c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Office of Epidemiology and Biostatistics   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Endometrial cancer; Fish; Omega 3

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESTROGEN; GESTAGEN; ICOSAPENTAENOIC ACID; ORAL CONTRACEPTIVE AGENT; VITAMIN D; OMEGA 3 FATTY ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY SIZE; CANCER RISK; DIETARY INTAKE; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FAT INTAKE; FEMALE; FISH; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HISTOLOGY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENARCHE; OBESITY; ORAL CONTRACEPTIVE USE; POSTMENOPAUSE; PROSPECTIVE STUDY; VITAMIN SUPPLEMENTATION; AGED; BLOOD; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; OBSERVATIONAL STUDY; OVERWEIGHT; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; WOMEN'S HEALTH;

AGED; BIOMARKERS; BODY MASS INDEX; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENDOMETRIAL NEOPLASMS; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; WOMEN'S HEALTH;

EID: 84929658413     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.098988     Document Type: Article

References (55)

1. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605-21.
2. Wallace AE, Gibson DA, Saunders PT, Jabbour HN. Inflammatory events in endometrial adenocarcinoma. J Endocrinol 2010;206:141-57.
3. Dossus L, Becker S, Rinaldi S, Lukanova A, Tjonneland A, Olsen A, Overvad K, Chabbert-Buffet N, Boutron-Ruault MC, Clavel-Chapelon F, et al. Tumor necrosis factor (TNF)-a, soluble TNF receptors and endometrial cancer risk: the EPIC study. Int J Cancer 2011;129: 2032-7.
4. Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 2010;17:1007-19.
5. Wang T, Rohan TE, Gunter MJ, Xue X,Wactawski-Wende J, Rajpathak SN, Cushman M, Strickler HD, Kaplan RC, Wassertheil-Smoller S, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev 2011;20:971-7.
6. Brasky TM, Moysich KB, Cohn DE, White E. Non-steroidal antiinflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol 2013;128:113-9.
7. Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E. Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol 2012;176:1002-13.
8. Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 2009;63:1154-6.
9. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SM, Farhoudi F, Hosseininezhad SJ, Tavallaei S, Vejdani A, Azimi-Nezhad M, et al. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol 2009;64: 321-7.
10. Malekshahi Moghadam A, Saedisomeolia A, Djalali M, Djazayery A, Pooya S, Sojoudi F. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med J 2012;53:615-9.
11. Micallef MA, Garg ML. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 2009;204:476-82.
12. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009;81: 187-91.
13. Ebert AD, Bartley J, David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions-old answers? Eur J Obstet Gynecol Reprod Biol 2005;122:144-50.
14. Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE. Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19: 1033-41.
15. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008;15:485-97.
16. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-9.
17. Brasky TM, Neuhouser ML, Cohn DE, White E. Associations of longchain v-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort. Am J Clin Nutr 2014;99:599-608.
18. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr., Kris-Etherton P, Goldberg IJ, Kotchen TA, et al. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. J Nutr 2001;131:132-46.
19. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33.
20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
21. Anderson GL, Manson J,Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13(9 Suppl):S5-17.
22. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13(9 Suppl):S18-77.
23. Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol 2003;13(9 Suppl):S98-106.
24. Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B, Ockene J. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol 2003;13(9 Suppl):S87-97.
25. Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 2003;13(9 Suppl):S78-86.
26. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13(9 Suppl):S107-21.
27. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87.
28. University of Minnesota. Nutrient data system for research 2007-2-5. 2007. Available from: http://www.ncc.umn.edu/products/databasefaqs. html.
29. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(4 Suppl):1220S-8S;discussion 1229S-31S.
30. Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, et al. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 2009;114:155-67.
31. Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, Dossus L, Biessy C, Vineis P, Sacerdote C, Berrino F, et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 2006;118:2832-9.
32. Arem H, Neuhouser ML, Irwin ML, Cartmel B, Lu L, Risch H, Mayne ST, Yu H. Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study. Eur J Nutr 2013;52:1251-60.
33. Fernandez E, Chatenoud L, La Vecchia C, Negri E, Franceschi S. Fish consumption and cancer risk. Am J Clin Nutr 1999;70:85-90.
34. Shu XO, Zheng W, Potischman N, Brinton LA, Hatch MC, Gao YT, Fraumeni JF Jr. A population-based case-control study of dietary factors and endometrial cancer in Shanghai, People's Republic of China. Am J Epidemiol 1993;137:155-65.
35. Terry P, Wolk A, Vainio H, Weiderpass E. Fatty fish consumption lowers the risk of endometrial cancer: a nationwide case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 2002;11:143-5.
36. Xu WH, Dai Q, Xiang YB, Zhao GM, Zheng W, Gao YT, Ruan ZX, Cheng JR, Shu XO. Animal food intake and cooking methods in relation to endometrial cancer risk in Shanghai. Br J Cancer 2006;95: 1586-92.
37. McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control 2000;11:965-74.
38. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077-85.
39. Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993;71:3575-81.
40. Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, Kuzuya K, Nakamura S, Tokudome S. Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer. Jpn J Cancer Res 1996;87:1001-9.
41. Jain MG, Howe GR, Rohan TE. Nutritional factors and endometrial cancer in Ontario, Canada. Cancer Control 2000;7:288-96.
42. Arem H, Gunter MJ, Cross AJ, Hollenbeck AR, Sinha R. A prospective investigation of fish, meat and cooking-related carcinogens with endometrial cancer incidence. Br J Cancer 2013;109:756-60.
43. Bandera EV, Kushi LH, Moore DF, Gifkins DM, McCullough ML. Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Causes Control 2007;18:967-88.
44. Zheng W, Kushi LH, Potter JD, Sellers TA, Doyle TJ, Bostick RM, Folsom AR. Dietary intake of energy and animal foods and endometrial cancer incidence. The Iowa women's health study. Am J Epidemiol 1995;142:388-94.
45. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB,Wolk A, Wentzensen N, Weiss NS, Webb PM, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013;31: 2607-18.
46. Kantor ED, Lampe JW, Kratz M, White E. Lifestyle factors and inflammation: associations by body mass index. PLoS ONE 2013;8: e67833.
47. Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis. Int J Cancer 2013;132:1146-55.
48. Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 2008;67: 19-27.
49. Witt PM, Christensen JH, Ewertz M, Aardestrup IV, Schmidt EB. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre-and postmenopausal women: a randomised, double-blind, placebocontrolled trial. Br J Nutr 2010;104:318-25.
50. Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer 2011;63:930-9.
51. Wu WH, Lu SC, Wang TF, Jou HJ, Wang TA. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women. Eur J Clin Nutr 2006;60:386-92.
52. Young LR, Raatz SK, Thomas W, Redmon JB, Kurzer MS. Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women. Nutr Metab (Lond) 2013;10:36.
53. Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK. v-3 Fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr 2010;91: 1185-94 .
54. Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 2008;68: 5619-27.
55. Horner NK, Patterson RE, Neuhouser ML, Lampe JW, Beresford SA, Prentice RL. Participant characteristics associated with errors in selfreported energy intake from the Women's Health Initiative foodfrequency questionnaire. Am J Clin Nutr 2002;76:766-73.